Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.
Nature immunology
View this publicationNature immunology
View this publicationLung cancer (Amsterdam, Netherlands)
View this publicationScience immunology
View this publicationAmerican journal of translational research
View this publicationHistopathology
View this publicationInternational journal of radiation oncology, biology, physics
View this publicationCancer research
View this publicationMolecular therapy : the journal of the American Society of Gene Therapy
View this publicationEuropean urology oncology
View this publicationClinical & translational immunology
View this publication